• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is Cooper Companies (COO) Undervalued As Its CEO Exit Triggers A Leadership Reset?

    Simply Wall St·11/06/2026 02:37:44
    Listen to the news

    Cooper Companies (COO) is in the middle of a major leadership reset after Albert White stepped down as CEO and director, with veteran healthcare executive Walter Rosebrough taking over operational oversight as Executive Chair.

    Recent price action around Cooper Companies suggests investors are reassessing the risk and opportunity mix as this reshuffle plays out. The 7 day share price return of 5.24% and 30 day gain of 12.53% come after a 90 day share price decline of 14.46% and a year to date fall of 21.71%. The 1 year total shareholder return is down 7.97% and the 5 year total shareholder return has declined 38.15%, hinting that short term momentum has picked up against a weaker longer run record.

    See how other healthcare and medical device players with fresher leadership stories compare by reviewing our curated list of 21 high quality undiscovered gems alongside Cooper Companies.

    Bulls see Cooper Companies as a profitable eyecare and women’s health specialist that has been marked down too far. Bears point to the long slide in returns. Which side do the current valuation markers lean toward?

    Most Popular Narrative: 4% Undervalued

    Compared with the last close of $63.50, the most followed narrative puts Cooper Companies closer to a fair value of $66.21, which frames today’s price as a discount rather than a premium.

    Company wide efforts to streamline operations through shared services, restructuring and AI enabled inventory optimization, combined with record free cash flow in Q3 2026 and reiterated guidance for about US$2.2b of free cash flow over 2026 to 2028, create scope for improved working capital efficiency, stronger net margins and higher free cash flow yield.

    See why 18 investors see Cooper Companies as 4% undervalued.

    Result: Fair Value of $66.21 (UNDERVALUED)

    Still, this bullish Cooper Companies story can be knocked off course if CooperSurgical legal issues demand more cash, or if Asia Pacific softness and hydrogel rationalization drag on reported growth.

    Find out about the key risks to this Cooper Companies narrative.

    Next Steps

    Sentiment around Cooper Companies is split, which is exactly why it helps to review the full data set and make a call quickly for yourself. To see which positives other investors are focused on, take a closer look at the 4 key rewards.

    Looking for more Cooper Companies style ideas?

    If Cooper Companies has your attention, do not stop here. Broaden your watchlist with a few focused stock ideas built from clear, data driven filters.